HK1125038A1 - Iontophoresis preparation for treatment of breast cancer and/or mastitis - Google Patents

Iontophoresis preparation for treatment of breast cancer and/or mastitis

Info

Publication number
HK1125038A1
HK1125038A1 HK09102786.5A HK09102786A HK1125038A1 HK 1125038 A1 HK1125038 A1 HK 1125038A1 HK 09102786 A HK09102786 A HK 09102786A HK 1125038 A1 HK1125038 A1 HK 1125038A1
Authority
HK
Hong Kong
Prior art keywords
mastitis
treatment
breast cancer
iontophoresis preparation
iontophoresis
Prior art date
Application number
HK09102786.5A
Other languages
English (en)
Inventor
Toshio Inagi
Makoto Kanebako
Hiroshi Terada
Kimiko Makino
Masakazu Toi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of HK1125038A1 publication Critical patent/HK1125038A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK09102786.5A 2005-10-12 2009-03-23 Iontophoresis preparation for treatment of breast cancer and/or mastitis HK1125038A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005297565 2005-10-12
PCT/JP2006/320320 WO2007043580A1 (ja) 2005-10-12 2006-10-11 乳癌及び／又は乳腺炎治療用イオントフォレシス製剤

Publications (1)

Publication Number Publication Date
HK1125038A1 true HK1125038A1 (en) 2009-07-31

Family

ID=37942810

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09102786.5A HK1125038A1 (en) 2005-10-12 2009-03-23 Iontophoresis preparation for treatment of breast cancer and/or mastitis

Country Status (9)

Country Link
US (2) US8034824B2 (xx)
EP (1) EP1935413A4 (xx)
JP (1) JP4000185B2 (xx)
KR (1) KR101344600B1 (xx)
CN (1) CN101287454B (xx)
CA (1) CA2625042C (xx)
HK (1) HK1125038A1 (xx)
RU (1) RU2008118363A (xx)
WO (1) WO2007043580A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011135904A (ja) 2008-04-18 2011-07-14 Kowa Co 乳癌及び／又は乳腺炎治療用イオントフォレシス製剤
US9220680B2 (en) 2012-07-13 2015-12-29 South Dakota State University Compositions and methods for localized drug delivery through mammary papillae
WO2015106094A1 (en) * 2014-01-10 2015-07-16 Atossa Genetics Inc. Transpapillary methods and compositions for diagnosing and treating breast conditions
ES2949838T3 (es) * 2015-05-06 2023-10-03 Zoetis Services Llc Formulación de hidrogel con adherencia leve
EP3307280B1 (en) 2015-06-11 2021-10-27 Rejoy Treatment of sexual dysfunction
CN105311741A (zh) * 2015-11-17 2016-02-10 深圳市一体太糖科技有限公司 一种电刺激传导介质及带传导介质的电刺激电极
MX2020002649A (es) 2017-09-11 2020-09-25 Atossa Therapeutics Inc Metodos para hacer y usar endoxifeno.
CN107854770B (zh) * 2017-10-20 2020-11-24 西安交通大学医学院第一附属医院 一种有机硒负离子导入辅助乳腺癌恢复装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2280046A1 (en) * 1997-02-17 1998-08-20 Kowa Co., Ltd. Device for iontophoresis
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
US20030092774A1 (en) * 2001-10-17 2003-05-15 Parkinson Thomas M. Methods for treating neoplastic, angiogenic, vascular, fibroblastic, and/or immunosuppressive iregularities of the eye and/or joint via administration of combretastatin based medicaments, and iontophoretic devices for delivering combretastatin based medicaments
EP1578421A4 (en) 2003-01-02 2009-04-22 Femmepharma Holding Co Inc PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND BREAST CONDITIONS
JP2004300147A (ja) 2003-03-17 2004-10-28 Takeda Chem Ind Ltd 受容体拮抗剤
GB0312309D0 (en) * 2003-05-29 2003-07-02 Gaslini Children S Hospital G Targeted liposome
JP2011135904A (ja) 2008-04-18 2011-07-14 Kowa Co 乳癌及び／又は乳腺炎治療用イオントフォレシス製剤

Also Published As

Publication number Publication date
US8362027B2 (en) 2013-01-29
CA2625042C (en) 2013-12-31
KR20080055882A (ko) 2008-06-19
JP4000185B2 (ja) 2007-10-31
US8034824B2 (en) 2011-10-11
EP1935413A1 (en) 2008-06-25
WO2007043580A1 (ja) 2007-04-19
CA2625042A1 (en) 2007-04-19
EP1935413A4 (en) 2013-01-23
CN101287454B (zh) 2011-07-20
JPWO2007043580A1 (ja) 2009-04-16
US20090281063A1 (en) 2009-11-12
US20110295189A1 (en) 2011-12-01
KR101344600B1 (ko) 2013-12-26
CN101287454A (zh) 2008-10-15
RU2008118363A (ru) 2009-11-20

Similar Documents

Publication Publication Date Title
EP1872124A4 (en) DIAGNOSTIC MARKERS FOR THE TREATMENT AND EVOLUTION OF BREAST CANCER AND METHODS OF USE
EP1968607A4 (en) TREATMENT OF CANCER AND OTHER DISEASES
HRP20150175T1 (xx) Sredstva za i postupci lijeäśenja tumorskih bolesti
EP1811844A4 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CANCER
ZA200800907B (en) Treatment of cancer
IL227841A0 (en) Dihydropyridinones for the treatment of cancer
HK1125038A1 (en) Iontophoresis preparation for treatment of breast cancer and/or mastitis
IL188430A0 (en) Treatment of tumors
GB0504988D0 (en) Device and method for the treatment of diseased tissue such as tumors
EP1814909A4 (en) USE OF AIMP2DX2 FOR THE DIAGNOSIS AND TREATMENT OF CANCER
EP2094866A4 (en) DIAGNOSIS AND TREATMENT OF BREAST CANCER
EP1869212A4 (en) USE OF ID4 FOR DIAGNOSIS AND TREATMENT OF CANCER
HK1100484A1 (en) Application of n-butylidenephthalide in preparing cancer treatment medication
IL182993A0 (en) Treatment of mastitis
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
EP1877420A4 (en) POLYTHERAPY FOR THE TREATMENT OF CANCER
GB0520067D0 (en) Treatment of cancer
EP1797430A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
EP1846013A4 (en) TREATMENT OF SKIN DISEASES
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1766051A4 (en) METHOD FOR IDENTIFYING BREAST CANCER RISK AND TREATMENTS THEREOF
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
IL180709A0 (en) Treatment of tumours
GB0410379D0 (en) Treatment of cancer
GB0423273D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151011